Quantum BioPharma Stock Forward View - Accumulation Distribution
| QNTM Stock | 3.94 0.26 6.19% |
Quantum Stock outlook is based on your current time horizon. Although Quantum BioPharma's naive historical forecasting may sometimes provide an important future outlook for the firm, we suggest always cross-verifying it against solid analysis of Quantum BioPharma's systematic risk associated with finding meaningful patterns of Quantum BioPharma fundamentals over time.
As of now the rsi of Quantum BioPharma's share price is below 20 indicating that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (3.44) | EPS Estimate Current Year (11.36) | EPS Estimate Next Year (5.16) | Wall Street Target Price 44.917 | EPS Estimate Current Quarter (3.70) |
Using Quantum BioPharma hype-based prediction, you can estimate the value of Quantum BioPharma from the perspective of Quantum BioPharma response to recently generated media hype and the effects of current headlines on its competitors.
Quantum Relative Strength Index
Quantum BioPharma Hype to Price Pattern
Investor biases related to Quantum BioPharma's public news can be used to forecast risks associated with an investment in Quantum. The trend in average sentiment can be used to explain how an investor holding Quantum can time the market purely based on public headlines and social activities around Quantum BioPharma. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Quantum BioPharma's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Quantum BioPharma.
Quantum BioPharma after-hype prediction price | USD 3.96 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Quantum BioPharma to cross-verify your projections. Quantum BioPharma Additional Predictive Modules
Most predictive techniques to examine Quantum price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Quantum using various technical indicators. When you analyze Quantum charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 9363.64 | 3095.0 |
| Check Quantum BioPharma Volatility | Backtest Quantum BioPharma | Information Ratio |
Quantum BioPharma Trading Date Momentum
| On February 09 2026 Quantum BioPharma was traded for 3.94 at the closing time. The top price for the day was 4.05 and the lowest listed price was 3.80 . The trading volume for the day was 50.1 K. The trading history from February 9, 2026 did not cause price change. The trading delta at closing time against the current closing price is 1.78% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Quantum BioPharma to competition |
Other Forecasting Options for Quantum BioPharma
For every potential investor in Quantum, whether a beginner or expert, Quantum BioPharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Quantum Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Quantum. Basic forecasting techniques help filter out the noise by identifying Quantum BioPharma's price trends.Quantum BioPharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Quantum BioPharma stock to make a market-neutral strategy. Peer analysis of Quantum BioPharma could also be used in its relative valuation, which is a method of valuing Quantum BioPharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Quantum BioPharma Market Strength Events
Market strength indicators help investors to evaluate how Quantum BioPharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Quantum BioPharma shares will generate the highest return on investment. By undertsting and applying Quantum BioPharma stock market strength indicators, traders can identify Quantum BioPharma entry and exit signals to maximize returns.
| Accumulation Distribution | 3095.0 | |||
| Daily Balance Of Power | (1.04) | |||
| Rate Of Daily Change | 0.94 | |||
| Day Median Price | 3.93 | |||
| Day Typical Price | 3.93 | |||
| Price Action Indicator | (0.11) | |||
| Period Momentum Indicator | (0.26) |
Quantum BioPharma Risk Indicators
The analysis of Quantum BioPharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Quantum BioPharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting quantum stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 6.05 | |||
| Standard Deviation | 9.27 | |||
| Variance | 85.99 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Quantum BioPharma
The number of cover stories for Quantum BioPharma depends on current market conditions and Quantum BioPharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Quantum BioPharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Quantum BioPharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Quantum BioPharma Short Properties
Quantum BioPharma's future price predictability will typically decrease when Quantum BioPharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Quantum BioPharma often depends not only on the future outlook of the potential Quantum BioPharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Quantum BioPharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.1 M | |
| Cash And Short Term Investments | 7.2 M |
Check out Historical Fundamental Analysis of Quantum BioPharma to cross-verify your projections. To learn how to invest in Quantum Stock, please use our How to Invest in Quantum BioPharma guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Will Biotechnology sector continue expanding? Could Quantum diversify its offerings? Factors like these will boost the valuation of Quantum BioPharma. Anticipated expansion of Quantum directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Quantum BioPharma data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Quantum BioPharma is measured differently than its book value, which is the value of Quantum that is recorded on the company's balance sheet. Investors also form their own opinion of Quantum BioPharma's value that differs from its market value or its book value, called intrinsic value, which is Quantum BioPharma's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Quantum BioPharma's market value can be influenced by many factors that don't directly affect Quantum BioPharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Quantum BioPharma's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Quantum BioPharma should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Quantum BioPharma's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.